Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stroke care at a distance: can video consultations speed up Life-Saving treatment?

NCT ID NCT07721129

Not yet recruiting Disease control Sponsor: Oman Ministry of Health Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a TeleStroke network can help peripheral hospitals in Oman safely give clot-busting drugs (alteplase or tenecteplase) to people having an acute ischemic stroke. A remote neurologist will assess patients via video, review scans, and guide the local medical team. The goal is to see if this approach increases the number of patients treated within the critical 4.5-hour window and improves their recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
clot-busting drugs (alteplase or tenecteplase) given through a vein, guided by a remote neurologist via video
What this could lead to
If it works, this could expand access to emergency stroke treatment in underserved areas, potentially reducing disability and death from stroke.
What could go wrong
This is a relatively small, region-specific trial. The benefit depends on reliable technology and quick coordination, which may not work in all settings. There is a risk of bleeding from the clot-busting drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE ISCHEMIC STROKE, ACUTE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.